← FTSE 100
Episodes featuring FTSE 100
35 episodes, newest first.
- Nov 20, 2026
European sell-off exposes winners and losersStock MoversNov 20, 2026 - Nov 20, 2026
AI exuberance meets Britain’s housing squeezeMerryn Talks MoneyNov 20, 2026 - Nov 17, 2026
Nvidia’s sell-off tests AI’s market foundationsUnhedgedNov 17, 2026 - Nov 8, 2026
Growth investors reassess AI bets and portfolio resilienceEquity Mates Investing PodcastNov 8, 2026 - Nov 6, 2026
Small-cap warnings test investors’ discipline after market sell-offUK Small/Mid Caps with Paul ScottNov 6, 2026 - Nov 6, 2026
UK shares weaken as construction warnings expose fragile earningsUK Small/Mid Caps with Paul ScottNov 6, 2026 - Nov 5, 2026
Howden’s US opportunity tests a value investor’s convictionThe Acquirers PodcastNov 5, 2026 - Nov 4, 2026
Portfolio discipline beats market timing and investing mythsMerryn Talks MoneyNov 4, 2026 - Oct 28, 2026
SK Hynix rides AI-memory demand as computing diversifiesStock MoversOct 28, 2026 - Oct 26, 2026
Computacenter lifts outlook as UK market roundup turns positiveUK Small/Mid Caps with Paul ScottOct 26, 2026 - Oct 18, 2026
Crisis appointments expose the limits of glass cliff evidenceThe HCL Review PodcastOct 18, 2026 - Oct 15, 2026
AI market fears spread from stocks to creditUnhedgedOct 15, 2026 - Oct 14, 2026
Passive investing’s hidden bet on America and big techMerryn Talks MoneyOct 14, 2026 - Oct 12, 2026
ITM Power leads a mixed morning for UK sharesUK Small/Mid Caps with Paul ScottOct 12, 2026 - Oct 8, 2026
Paul Scott’s morning roundup weighs fresh small-cap signalsUK Small/Mid Caps with Paul ScottOct 8, 2026 - Oct 7, 2026
Paul Scott flags market weakness and standout portfolio stocksUK Small/Mid Caps with Paul ScottOct 7, 2026 - Oct 4, 2026
Portfolio losses test conviction in Axon, QXO and Hub24Equity Mates Investing PodcastOct 4, 2026 - Sep 25, 2026
HelloFresh slumps as UBS reshapes Europe’s market storyStock MoversSep 25, 2026 - Sep 23, 2026
Buy-to-let shifts from leveraged bet to yield businessMerryn Talks MoneySep 23, 2026 - Aug 17, 2026
Mining gains meet drug-trial surprises across European marketsStock MoversAug 17, 2026 - Aug 17, 2026
European miners rise as drug trials reshape pharma stocksStock MoversAug 17, 2026 - Aug 12, 2026
Strong earnings meet stubborn valuation fearsEquity Mates Investing PodcastAug 12, 2026 - Aug 11, 2026
Cramer tests AI valuations against real-world growthMad Money w/ Jim CramerAug 11, 2026 - Jul 29, 2026
European stocks jump as Reckitt and Kering post strong earningsStock MoversJul 29, 2026